Company Overview

Marpai, Inc. is a U.S.-based healthcare technology company operating in the healthcare services and health insurance administration industries. The company provides an artificial intelligence–driven platform designed to function as a third-party administrator (TPA) for self-funded employer health plans. Its core value proposition centers on using predictive analytics and machine learning to reduce healthcare costs, improve clinical outcomes, and enhance the member experience for employer-sponsored health plans.

Marpai primarily serves self-insured employers, including small to mid-sized businesses, and their covered employees. The company positions itself as a technology-first alternative to traditional TPAs by integrating AI-driven care navigation, claims administration, and population health management. Marpai was founded in 2019 and became a publicly traded company in 2021 through an initial public offering on the Nasdaq Capital Market under the ticker MRAI. Since going public, the company has pursued growth through acquisitions to scale operations and expand administrative capabilities.

Business Operations

Marpai operates as a single-reportable segment focused on AI-powered health plan administration. Revenue is generated primarily through per-member-per-month fees paid by employer clients for administering self-funded health plans, including claims processing, care coordination, and analytics-driven cost containment services. The company integrates proprietary AI algorithms to identify high-risk members, optimize care pathways, and manage healthcare utilization.

Operations are primarily domestic within the United States, where Marpai controls technology platforms, clinical analytics tools, and administrative infrastructure. The company expanded its operational capabilities through the acquisition of Maestro Health and Continental Benefits, LLC, both of which operate as subsidiaries and provide established TPA services, client relationships, and operational scale. These subsidiaries enhance Marpai’s ability to offer end-to-end health plan administration while embedding its AI technology across legacy systems.

Strategic Position & Investments

Marpai’s strategic direction emphasizes scaling its AI-driven TPA model through a combination of organic client growth and targeted acquisitions. Key growth initiatives include expanding employer adoption of self-funded plans, increasing member enrollment per client, and integrating advanced analytics to further reduce medical cost trends. The company positions its technology as a differentiator in a fragmented TPA market dominated by legacy administrators with limited automation.

Major investments have centered on acquisitions that provide immediate revenue, experienced personnel, and operational infrastructure. The acquisitions of Maestro Health and Continental Benefits, LLC are central to this strategy, enabling Marpai to rapidly expand its administrative footprint and cross-sell AI-enhanced services. The company continues to invest in machine learning, predictive healthcare analytics, and care management technologies to strengthen its competitive positioning.

Geographic Footprint

Marpai is headquartered in New York, United States, and conducts the vast majority of its operations domestically. Its services are delivered nationwide, supporting employer clients and plan members across multiple U.S. regions through centralized technology platforms and distributed administrative teams.

While Marpai does not maintain significant international operations, its market presence spans multiple states through its subsidiaries and client base. The company’s geographic influence is primarily tied to the U.S. employer-sponsored health insurance market, where regulatory frameworks and healthcare cost pressures align with its self-funded plan offerings.

Leadership & Governance

Marpai was founded by Avi Meir, who continues to shape the company’s strategic vision around the application of artificial intelligence to healthcare cost management. Leadership emphasizes data-driven decision-making, automation of healthcare administration, and aligning financial incentives with improved patient outcomes.

Key executives include:

• Avi Meir – Chief Executive Officer and Founder
• Fred Howe – Chief Financial Officer
• Dan Glaser – Chief Operating Officer

The leadership team oversees corporate strategy, capital allocation, technology development, and integration of acquired businesses, with governance aligned to public company standards and regulatory requirements applicable to Nasdaq-listed healthcare technology firms.